A comparative study of endothelium-derived relaxing factor-mediated relaxation and smooth muscle cell function in arterial and venous vein bypass grafts

Vascular

Volumn 4, Issue 2, 1996, Pages 150-160

  Davies, M G ^a   Klyachkin, M L ^a   Svendsen, E ^b   Hagen, P O ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

endothelial and smooth muscle cell; intimal hyperplasia; rabbit; vein grafts

Indexed keywords

ACETYLCHOLINE; BRADYKININ; ENDOTHELIUM DERIVED RELAXING FACTOR; HISTAMINE; NITROPRUSSIDE SODIUM; NORADRENALIN; POTASSIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; BYPASS SURGERY; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM; HISTOLOGY; MALE; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE;

EID: 0029989543     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721099600400207     Document Type: Article

References (44)

1. Ip JH, Fuster V, Badimon L, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: The role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990; 15: 1667–1687.
2. Fuchs JCA, Mitchener JS, Hagen P-O. Postoperative changes in autologous vein grafts. Ann Surg 1978; 188: 1–15.
3. Dobrin PB, Littooy FN, Endean ED. Mechanical factors predisposing to intimal hyperplasia and medial thickening in autogenous vein grafts. Surgery 1989: 105: 393–400.
4. Makhoul RG, Davis WS, Mikat EM, McCann RL, Hagen P-O. Responsiveness of vein grafts to stimulation with norepinephrine and 5-hydroxytryptamine. J Vasc Surg 1987; 6: 32–38.
5. Cross KS, EI-Sanadiki MN, Murray JJ, Mikat EM, McCann RL, Hagen P-O. Functional abnormalities of experimental autogenous vein graft neoendothelium. Ann Surg 1988; 208: 631–638.
6. Radic ZS, O'Donohoe MK, Schwartz LB, et al. Alterations in serotonergic receptor expression in experimental vein grafts. J Vasc Surg 1991; 14: 40–47.
7. Towne JB. The role of fibrointimal hyperplasia in vein graft failure. J Vasc Surg 1989; 10: 583–585.
8. Szilagyi DE, Hageman JH, Smith RF, Elliott JP, Brown F, Dietz P. Autogenous vein grafting in femoropopliteal atherosclerosis: The limits of its effectiveness. Surgery 1979; 86: 536–551.
9. Bourassa MG, Fischer LD, Campeau L, Gillespie MJ, McConney M, Lesperance J. Long-term fate of bypass grafts: The coronary artery surgery study (CASS) and the Montreal Heart Institute experience. Circulation 1985; 72 (suppl V): 71–78.
10. Campeau L, Enjalbert M, Lesperance J, Vaislic C, Grondin CM, Bourassa MG. Atherosclerosis and late closure of aorto-coronary saphenous vein grafts: Sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years and 10 to 12 years after surgery. Circulation 1983; 68 (suppl II): 1–7.
11. Ramos JR, Berger K, Mansfield PB, Sauvage LR. Histologic fate and endothelial changes of distended and non-distended vein grafts. Ann Surg 1976; 183: 205–228.
12. Adcock GLD, Adcock OT Jr, Wheeler JR, et al. Arterialization of reversed autogenous vein grafts: Quantitative light and electron microscopy of canine jugular vein grafts harvested and implanted using standard or improved techniques. J Vasc Surg 1987; 6: 283–295.
13. Svendsen E, Dalen H, Moland J, Engedal H. A quantitative study of endothelial cell injury in aorto-coronary vein grafts. J Cardiovasc Surg (Torino) 1986; 27: 65–67.
14. Brody WR, Kosek JG, Angell WV. Changes in vein grafts following aorto-coronary bypass induced by pressure and ischemia. J Thorac Cardiovasc Surg 1972; 64: 847–854.
15. Kohler TR, Kirkman TR, Clowes AW. The effect of rigid external support on vein graft adaptation to the arterial circulation. J Vasc Surg 1989; 9: 277–285.
16. Schwartz LB, O'Donohoe MK, Purut CM, Mikat EM, Hagen P-O, McCann RL. Myointimal thickening in experimental vein grafts is dependent on wall tension. J Vasc Surg 1992; 15: 176–186.
17. Dobrin PB, Littooy FN, Golan J, et al. Mechanical and histologic changes in canine vein grafts. J Surg Res 1988; 14: 259–260.
18. Rubanyi GM, ed. Cardiovascular Significance of Endothelium-Derived Vasoactive Factors. 1st ed. Mount Kisco, New York: Futura Publishing Company, 1991.
19. Dries D, Mohammad SF, Woodward SC, Nelson RM. The influence of harvesting technique on endothelial preservation in saphenous veins. J Surg Res 1992; 52: 219–225.
20. Sayers RD, Watt PAC, Muller S, Bell PRF, Thurston H. Structural and functional muscle injury after surgical preparation of reversed and non-reversed (in situ) saphenous vein bypass grafts. Br J Surg 1991; 78: 1256–1258.
21. Sayers RD, Watt PAC, Muller S, Bell PRF, Thurston H. Endothelial cell injury secondary to surgical preparation of reversed and in situ saphenous vein bypass grafts. Eur J Vasc Surg 1992; 6: 354–361.
22. Schwartz LB, Radic ZS, O'Donohoe MK, McCann RL, Mikat EM, Hagen P-O. Functional and morphological endothelial damage in rabbit external jugular veins stored in heparinized normal saline. Blood Vessels 1991; 28: 511–519.
23. Schwartz LB, Massey MF, Davies MG, Klyachkin ML, Hagen P-O, McCann RL. Effect of in vitro pressurization on human saphenous vein vasoreactivity (abstract) FASEB J 1992; 6: A1041.
24. Quist WC, LoGerfo FW. Prevention of smooth muscle cell phenotypic modulation in vein grafts: A histomorphometric study. J Vasc Surg 1992; 16: 225–231.
25. Bush HL, Jakubowski JA, Curl R, Deykin D, Nabseth DC. The natural history of endothelial structure and function in arterialized vein grafts. J Vasc Surg 1986; 3: 204–215.
26. Cambria RP, Megerman J, Abbott WM. Endothelial preservation in reversed and in situ autogenous vein grafts. A quantitative experimental study. Ann Surg 1985; 202: 50–55.
27. Magnant JG, Walsh DB, Schneider JR, James TW, Wagner RJ, Cronenwett JL. Differences in vasoreactivity of in situ and reversed vein grafts (abstract). J Vasc Surg 1992; 15: 1068.
28. O'Donohoe MK, Murchan PM, Marks P, Feely J, Feeley TM. Endothelium derived relaxing factor is absent in experimental in situ vein grafts. Eur J Vasc Surg 1993; 7: 144–150.
29. Miller VM, Bower TC, McCullough JL, Gloviczki P, Vanhoutte PM. Endothelium-dependent responses in nonreversed (in situ) vein grafts. J Vasc Med Biol 1990; 2: 155–162.
30. Goodfellow BS, Mikat EM. Simultaneous demonstration of collagen muscle and elastin elements in mammalian tissue. Lab Med 1988; 19: 243–244.
31. Finney DJ. Quantal responses and the tolerance distribution. In: Finney DJ, ed. Statistical Method in Biological Assay. London: Charles Griffin, 1978: 349–369.
32. Seidel CL, Lewis RM, Bowers R, et al. Adaptation of canine saphenous veins to grafting. Correlation of contractility and contractile protein content. Circ Res 1984; 55: 102–109.
33. Soliman AS, Tackett RL. Early alterations in vascular reactivity of autogenous saphenous vein grafts. Coronary Artery Disease 1992; 3: 523–527.
34. Soliman AS, Tackett RL. Altered responsiveness of saphenous vein grafts to norepinephrine and tyramine: Relation to tissue catecholamine stores. J Cardiovasc Pharmacol 1991; 17: 154–157.
35. Waris T, Loefstedt T, Partanen S, Smitten KV. Innervation of synergeic vein grafts in the rat: The regeneration of adrenergic nerves. J Surg Res 1984; 37: 472–478.
36. Massey MF, Davies MG, Svendsen E, et al. Ketanserin inhibits experimental vein graft intimal hyperplasia. J Surg Res 1993; 54: 530–538.
37. Robert RA. Bradykinin receptor characterization, distribution and mechanisms of signal transduction. Prog Growth Factor 1989; 1: 237–252.
38. Schwartz LB, Pence JC, Kerns BJ, Inglehart JD, McCann RL, Hagen P-O. Kinetics of vein graft cell division and function. Surgical Forum 1991; XLVII: 362–365.
39. Massey MF, Davies MG, Klyachkin ML, et al. Bradykinin responses in experimental vein grafts. J Vasc Med Biol 1993; 4: 122–127.
40. Linz W, Schoelkens BA. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 1992; 20: (suppl 9): S83–90.
41. O'Donohoe MK, Davies MG, Radic ZS, Mikat EM, Hagen P-O. Increased concentrations of angiotensin converting enzyme in the intimal hyperplasia of experimental vein grafts. J Cardiovasc Pharmacol 1994; 23: 594–601.
42. O'Donohoe MK, Schwartz LB, Radic ZS, Mikat EM, McCann RL, Hagen P-O. Chronic ACE inhibition reduces intimal hyperplasia in experimental vein grafts. Ann Surg 1991; 214: 727–732.
43. Cross KS, Sanadiki MN, Murray JJ, Mikat EM, McCann RL, Hagen P-O. Mast cell infiltration: A possible mechanism for vein graft vasospasm. Surgery 1988; 104: 171–177.
44. Ardissino D, Barberis P, De Servis S, et al. Abnormal coronary vasoconstriction as a predictor of restenosis after successful coronary angioplasty in patients with unstable angina pectoris. N Engl J Med 1991; 325: 1053–1057.